|
Jian Huang, Chief Physician, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Methylation | Immune Regulation | Myeloproliferative Tumors | Leukemia | Chronic Myeloid Leukemia | Clinical Research | Basic Research | Rare Blood Diseases | Hematology | Cancer |
|
Xi Jiang, Researcher, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Leukemia | Epigenetics | Dna Modification | Rna Modification | Chemotherapy Response | Small Molecule Inhibitors | Oncogenic Factors | Clinical Translation | Targeted Therapy | Drug Development |
|
Kai Wang, Professor, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Lung Cancer | Targeted Therapy | Immunotherapy | Efficacy Mechanisms | Microenvironment | Regulation | Anti-Cancer Drugs | Drug Development | Cancer Research | Oncology |
|
Xiaojun Xu, Chief Physician, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Immunotherapy | Childhood Leukemia | Pediatric Oncology | Cancer Treatment | Leukemia | Children | Therapy | Medical Research | Clinical Trials | Hematology |
|
Hui Lin, Chief Physician, Doctoral Supervisor, Vice Dean of the School of Biomedical Engineering and Instrument Science, Director of the Internet and Artificial Intelligence Office at the Affiliated Sir Run Run Shaw Hospital
Zhejiang University, Medical
Area of Focus
Liver Cancer | Molecular Mechanisms | Tumor | Targeted Therapy | Drug Development | Surgical Navigation | Digital Healthcare | Artificial Intelligence | Biomedical Engineering | Precision Medicine |
|
Wan Zhuo Xie, Chief Physician, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Hematology | Internal Medicine | Malignant Diseases | Clinical Research | Basic Research | Lymphoma | Blood Disorders | Cancer | Immunology | Therapy |
|
Hongyan Tong, Chief Physician, Associate Professor, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Mds | Pathogenesis | Treatment | Myeloid Leukemia | Refractory | Clinical Research | Basic Research | Hematology | Oncology | Blood Disorders |
|
Rongzhen Xu, Researcher, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Internal Medicine | Hematology | Hematologic Tumors | Etiology | Pathogenesis | Molecular Targeted Drugs | Anti-Tumor | Drug Development | Cancer Research | Oncology |
|
Hangping Yao, Researcher | Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Infectious Diseases: Infection | Immunity | Pathogens | Rapid Identification | H7N9 | Avian Influenza | Vaccine | Public Health | Outbreak | Control | Infection And Cancer: Infection | Cancer | Immune Response | Tumor Microenvironment | Oncogenesis | Chronic Infection | Viral Oncogenesis | Bacterial Oncogenesis | Inflammation | Therapy | Tumor Biology And Targeted Therapy: Tumor | Biology | Targeted Therapy | Ron Receptor | Monoclonal Antibodies | Immunohistochemistry | Prognosis | Molecular Mechanisms | Drug Targets | Cancer Treatment | Preclinical Research Of Antibodies And Antibody Drugs: Antibodies | Preclinical Research | Drug Development | Adc | Efficacy | Safety | Cancer Therapy | Humanized Antibodies | Clinical Application |
|
Qinghua Dong, Associate Researcher, Master's Supervisor, Deputy Director
Zhejiang University, Medical
Area of Focus
Tumor | Genes | Oncology | Cancer | Genetics | Biomarkers | Therapy | Molecular Biology | Drug Development | Pharmacology |
